Cost-effectiveness of vaccinating pregnant women against pandemic influenza in Colombia;Costo-efectividad de la vacunación contra influenza pandémica en mujeres embarazadas en Colombia

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 31, Issue 6, 2012, Pages 447-453

  Chocontá Piraquive, Luz Angela ^a   Guzmán, Nelson Alvis ^b   De La Hoz Restrepo, Y Fernando ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Colombia; Cost and cost analysis; H1N1 subtype; Immunization coverage; Influenza A virus; Influenza vaccines; Pregnant women

Indexed keywords

COHORT ANALYSIS; COST-BENEFIT ANALYSIS; HEALTH CARE; HOSPITAL SECTOR; INFLUENZA; MORTALITY; NUMERICAL MODEL; PREGNANCY; RISK FACTOR; VACCINATION; WOMENS HEALTH;

COLOMBIA;

INFLUENZA A VIRUS;

EID: 84866009597     PISSN: 10204989     EISSN: 16805348     Source Type: Journal    
DOI: 10.1590/s1020-49892012000600001     Document Type: Article

References (41)

1. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360(25): 2605-15.
2. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine-Preliminary Report. N Engl J Med. 2009;361(25):2424-35.
3. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361(25):2405-13.
4. Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet. 2010; 375(9708):6-9.
5. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2009;375(9708):56-66.
6. Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S, et al. Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in infants and children: A randomized trial. JAMA. 2010;303(1):37-46.
7. Plennevaux E, Sheldon E, Blatter M, Reeves-Hoché MK, Denis M. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: A preliminary report of two randomised controlled phase 2 trials. Lancet. 2010;375(9708):41-8.
8. World Health Organization. Statement from WHO Global Advisory Committee on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 vaccines. Disponible en: Www.who.int/vaccine-safety/GACVS-H1N1-Vaccine-Safety. pdf Acceso el 6 de marzo de 2012.
9. Centers for Disease Control and Prevention. CDC Advisors Make Recommendations for Use of Vaccine Against Novel H1N1. Disponible en: Http://www.cdc.gov/media/pressrel/2009/r090729b.htm Acceso el 6 de marzo de 2012.
10. Boon HL, Tahir AM. Pandemic H1N1 2009 (swine flu) and pregnancy. Elsevier. 2010;20(4):101-6.
11. Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95-100.
12. Jamieson DJ, Honein MA, Rasmussen SA, Williams JL, Swerdlow DL, Biggerstaff MS, et al. H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet. 2009;374(9688):451-8.
13. Siston AM, Rasmussen SA, Honein MA, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517-25.
14. Louie JK, Acosta M, Jamieson DJ, Honein MA, California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;362(1):27-35.
15. Kelly H, Mercer G, Cheng A. Quantifying the risk of pandemic influenza in pregnancy and indigenous people in Australia in 2009. Euro Surveill. 2009;14(50).
16. World Health Organization. Commission on Macroeconomics and Health. Macroeconomics and health: Investing in health for economic development. Report of the Commission on Macroeconomics and Health. Geneve, Switzerland: WHO; 2001.
17. Rey G. El virus pandémico A/H1N1 2009 en Colombia. Seminario enfermedades infecciosas y modelos matemáticos aplicados a la influenza pandémica. Bogotá D.C., Colombia: Universidad Nacional de Colombia; 2009.
18. Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: Current evidence and selected national policies. Lancet Infect Dis. 2008;8(1):44-52. (Pubitemid 351620939)
19. Donaldson LJ, Rutter PD, Ellis BM, Greaves FE, Mytton OT, Pebody RG, et al. Mortality from pandemic A/H1N1 2009 influenza in England: Public health surveillance study. BMJ. 2009;339:5213.
20. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, Hollingsworth TD, et al. Pandemic potential of a strain of influenza A (H1N1): Early findings. Science. 2009;324(5934):1557-61.
21. Dawood FS, Hope KG, Durrheim DN, Givney R, Fry AM, Dalton CB. Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009. PLoS One. 2010;5(3):9880.
22. Baker MG, Wilson N, Huang QS, Paine S, López L, Bandaranayake D, et al. Pandemic influenza A(H1N1)v in New Zealand: The experience from April to August 2009. Euro Surveill. 2009;14(34).
23. Institut de Veille Sanitaire. Bulletin Grippe A(H1N1) 2009 No. 79. Point de situation au 12 janvier 2010. París, Francia: INVS; 2010.
24. Presanis AM, De Angelis D, Hagy A, Reed C, Riley S, Cooper BS, et al. The severity of pandemic H1N1 influenza in the United States, from April to July 2009: A Bayesian analysis. PLoS Med. 2009;6(12):e1000207.
25. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, et al. Time lines of infection and disease in human influenza: A review of volunteer challenge studies. Am J Epidemiol. 2008;167(7):775-85. (Pubitemid 351451744)
26. Moreno J, De la Hoz F, Rico A, Cotes K, Porras A. Efectividad de la vacuna contra influenza: meta-análisis de literatura. Biomédica. 2009; 29(1):87-97.
27. Wood D J. Update on H1N1 vaccine immunogenicity, safety and effectiveness. World Health Organization. 2010. Disponible en: Http://www.who.int/immunization/sage/Influenza-2-H1N1-vaccine-immunogenicity-D- Wood-SAGE-April-2010.pdf Acceso el 7 de marzo de 2012.
28. Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: A multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2010;375(9708):56-66.
29. Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol Rev. 2006;28(1):47-53. (Pubitemid 44289088)
30. Center for Disease Control and Prevention. Interim results: Influenza A (H1N1) 2009 monovalent vaccination coverage-United States, October-December 2009. MMWR Morb Mortal Wkly Rep. 2010;59(2):44-8.
31. Porras-Ramírez A, Alvis-Guzmán N, Rico-Mendoza A, Alvis-Estrada L, Castañeda-Orjuela CA, Velandia-González MP, et al. Costo efectividad de la vacunación contra influenza en menores de 2 años y mayores de 65 años en Colombia. Rev Salud Publica. 2009;11(5):689-99.
32. Banco de la República de Colombia. Series estadísticas, tasas de cambio. Disponible en: Http://banrep.gov.co/series-estadisticas/see-ts- cam.htm Acceso el 7 de marzo de 2012.
33. Khazeni N, Hutton DW, Garber AM, Hupert N, Owens DK. Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009. Ann Intern Med. 2012;156(5).
34. Brouwers L, Cakici B, Camitz M, Tegnell A, Boman M. Economic consequences to society of pandemic H1N1 influenza 2009 - preliminary results for Sweden. Euro Surveill. 2009;14(37).
35. Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, et al. The transmissibility and control of pandemic influenza A (H1N1) virus. Science. 2009;326(5953):729-33.
36. Sypsa V, Pavlopoulou I, Hatzakis A. Use of an inactivated vaccine in mitigating pandemic influenza A(H1N1) spread: a modelling study to assess the impact of vaccination timing and prioritisation strategies. Euro Surveill. 2009;14(41):19356.
37. Baguelin M, Hoek AJ, Jit M, Flasche S, White PJ, Edmunds WJ. Vaccination against pandemic influenza A/H1N1v in England: a real-time economic evaluation. Vaccine. 2010;28(12):2370-84.
38. Beigi RH, Wiringa AE, Bailey RR, Assi TM, Lee BY. Economic value of seasonal and pandemic influenza vaccination during pregnancy. Clin Infect Dis. 2009;49(12):1784-92.
39. Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol. 2009;201(6):547-52.
40. Basta NE, Chao DL, Halloran ME, Matrajt L, Longini Jr IM. Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States. Am J Epidemiol. 2009;170(6):679-86.
41. Ciancio B, Sprenger M. Pandemic H1N1 Vaccine Effectiveness in Europe: Results of the I-MOVE Studies. Disponible en: http://www.who.int/vaccine- research/diseases/influenza/feb-17-2011-Bruno-Ciancio-ws.pdf Acceso el 4 de abril de 2012.